HLA-G in melanoma: can the current controversies be solved?

被引:41
作者
Chang, CC [1 ]
Ferrone, S [1 ]
机构
[1] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA
关键词
HLA-G; immunomodulation; malignancy; stress;
D O I
10.1016/S1044-579X(03)00027-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The potential role of HLA-G in tumor immune escape has stimulated interest in the analysis of HLA-G antigens in malignant cells. Malignant melanoma is the tumor which has been mostly analyzed for HLA-G expression. Results obtained by seven groups of investigators about HLA-G expression in 108 melanoma cell lines have been concordant. HLA-G mRNA has been found in about 50% of the cell lines tested, whereas HLA-G protein has been found in less than 1% of the cell lines analyzed. In contrast, results obtained from six groups of investigators about HLA-G protein expression in 133 melanoma lesions have been conflicting. The possible causes of these conflicting results as well as the reasons for the discrepancy in HLA-G expression between cultured melanoma cell lines and surgically removed lesions have been discussed. Lastly, data about the potential clinical relevance of HLA-G expression in melanoma has been reviewed. The available data in the literature strongly suggest that progress in this exciting research area would greatly benefit from experiments to solve the current controversies in the field. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:361 / 369
页数:9
相关论文
共 64 条
[31]   IFN-γ protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism [J].
Malmberg, KJ ;
Levitsky, V ;
Norell, H ;
de Matos, CT ;
Carlsten, M ;
Schedvins, K ;
Rabbani, H ;
Moretta, A ;
Söderström, K ;
Levitskaya, J ;
Kiessling, R .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (10) :1515-1523
[32]  
Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6
[33]   Eukaryotic translation initiation factor 4G is targeted for proteolytic cleavage by caspase 3 during inhibition of translation in apoptotic cells [J].
Marissen, WE ;
Lloyd, RE .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (12) :7565-7574
[34]   Oxygen sensors and angiogenesis [J].
Maxwell, PH ;
Ratcliffe, PJ .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2002, 13 (01) :29-37
[35]   HLA-G gene repression is reversed by demethylation [J].
Moreau, P ;
Mouillot, G ;
Rousseau, P ;
Marcou, C ;
Dausset, J ;
Carosella, ED .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (03) :1191-1196
[36]  
Moretta L, 2002, EUR J IMMUNOL, V32, P1205, DOI 10.1002/1521-4141(200205)32:5<1205::AID-IMMU1205>3.0.CO
[37]  
2-Y
[38]   GROWTH-FACTORS, PROTOONCOGENES AND HUMAN PLACENTAL DEVELOPMENT [J].
OHLSSON, R .
CELL DIFFERENTIATION AND DEVELOPMENT, 1989, 28 (01) :1-16
[39]   HLA-G protein expression is not induced during malignant transformation [J].
Pangault, C ;
Amiot, L ;
Caulet-Maugendre, S ;
Brasseur, F ;
Burtin, F ;
Guilloux, V ;
Drenou, B ;
Fauchet, R ;
Onno, M .
TISSUE ANTIGENS, 1999, 53 (04) :335-346
[40]   Cancer immunotherapy with peptide-based vaccines: What have we achieved? - Where are we going? [J].
Parmiani, G ;
Castelli, C ;
Dalerba, P ;
Mortarini, R ;
Rivoltini, L ;
Marincola, FM ;
Anichini, A .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (11) :805-818